연구용제품기자재 > 범용장비
Leica BOND RX -Multiplexing immunofluorescence 웨비나
라이카코리아(바이오시스템즈)
Cancer research continues to push the boundaries with new advancements in tissue analysis and biomarker detection. Now, more than ever, there is significant emphasis on understanding the underlying interaction between the immune system and the tumor microenvironment.
Multiplexing immunofluorescence (mIF) has greatly increased our understanding of solid tumor biology and immunology, including tumor-infiltrating lymphocytes and cancer-induced architectural alterations, and aided in novel immunology discoveries.
In this webinar, we will discuss how Akoya Biosciences Phenoptics assays support quantitative mIF to overcome the limitations imposed by conventional IHC methodologies. We will also discuss how our Opal assay kits and reagents can be integrated with the Leica BOND RX to automate your staining workflow to support consistent results for high-throughput studies.
* For Research Use Only. Not for use in diagnostic procedures |
||
This email was sent by: |
||
|
||
unsubscribe from this list | manage your profile | legal & privacy policy |
||
Copyright Leica Biosystems Nussloch GmbH 2019. |
||
|
본 정보는 "라이카코리아(바이오시스템즈)" (으)로 문의 바랍니다.